Meetings

Meeting Announcements

‘Mistress of Machines’ Kate Darling to deliver ISSRDC keynote address focused on robotics and society

International Space Station U.S. National Laboratory
Meeting Announcement

BOSTON (MA), June 4, 2024 – Kate Darling, a leader in exploring the intersection of robotics and society, will discuss intelligent machines in a keynote address on Wednesday, July 31, 2024, during the International Space Station Research and Development Conference (ISSRDC).

SNMMI Annual Meeting to take place June 8-11, 2024

Society of Nuclear Medicine and Molecular Imaging
Meeting Announcement

The Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

The field of nuclear medicine is undergoing rapid and widespread growth—offering patients increasingly precise, tailored, painless diagnosis and treatment with minimal side effects and exceptional results.

This year’s program will focus on new radiopharmaceuticals, instrumentation, and techniques for managing a wide range of diseases, from cancer, brain, and heart disease to infection and inflammation.

The meeting will convene more than 6,500 attendees from around the globe. With more than 100 scientific and CE sessions offered, as well as a completely reimagined Science Pavilion, there will be no shortage of high-quality education and cutting-edge research.

Meeting: Society of Nuclear Medicine and Molecular Imaging Annual Meeting

Neurocognitively-defined subtypes in bipolar disorder: a path to more personalized treatments

Brain & Behavior Research Foundation
Meeting Announcement

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Neurocognitively-Defined Subtypes in Bipolar Disorder: A Path to More Personalized Treatments” on Tuesday, June 11, 2024, at 2:00 pm ET. The presenter, Katherine E. Burdick, PhD, is the Jonathan F. Borus, MD Distinguished Chair in Psychiatry and the Vice Chair for Research in Psychiatry at Brigham and Women’s Hospital. She is the Director of the Mood and Psychosis Research Program at BWH and a Professor at Harvard Medical School. The host, Jeffrey Borenstein, M.D., is the President & CEO of the Brain & Behavior Research Foundation, and host of the public television series Healthy Minds.

Announcing Retro Biosciences as Tier 4 Sponsor of ARDD 2024

Aging Research and Drug Discovery
Meeting Announcement

The University of Copenhagen is excited to announce Retro Biosciences as a Tier 4 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.

Announcing Healthy Longevity Clinic as Tier 3 Sponsor of ARDD 2024

Aging Research and Drug Discovery
Meeting Announcement

The University of Copenhagen is excited to announce Healthy Longevity Clinic as a Tier 3 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.

Announcing Longevity Biotechnology Association as Tier 3 Sponsor of ARDD 2024

Aging Research and Drug Discovery
Meeting Announcement

The University of Copenhagen is excited to announce Longevity Biotechnology Association as a Tier 3 Sponsor of the 11th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 26 - August 30, 2024 on-site at the Ceremonial Hall, University of Copenhagen, and online.

Florida infection preventionist successfully advocates for staff growth, keeping pace with hospital’s expanding service lines

Association for Professionals in Infection Control
Meeting Announcement

In an era of hospital budget cuts and staffing freezes, a Florida hospital more than doubled staff positions for infection prevention and control (IPC) over a four-year period, reducing infections and creating opportunities for non-clinical team members to enter the field and excel.

Meeting: APIC 2024 Annual Conference

Surgical site infection rates and other secondary outcomes decrease dramatically at multi-state hospital system through standardized, preoperative, surgical, antibiotic practices

Association for Professionals in Infection Control
Meeting Announcement

Mortality, length of stay, readmissions, and surgical site infections (SSI) all declined after a six-state hospital system implemented a comprehensive surgical site infection (SSI) prevention bundle, according to a report presented today at the 2024 APIC Annual Conference.

Meeting: APIC 2024 Annual Conference

Redox Science Meets Medicine at the 26th International Conference on Redox Medicine 2024 this June in Paris

Mitochondria-Microbiota Task Force
Meeting Announcement

The 26th International Conference on Redox Medicine 2024 will take place this month, on June 27-28 at Fondation Biermans-Lapôtre in Paris, France. With 41+ communications and participants from 20 different countries, the conference promises a diverse exchange of knowledge and ideas.

To eliminate COVID-era bloodstream infections in heart, lung patients, Tampa Hospital had to innovate

Association for Professionals in Infection Control
Meeting Announcement

Recognizing an unusual prevalence of bloodstream infections (BSI) that threatened extremely ill patients receiving Extracorporeal Membrane Oxygenation, or ECMO, Tampa General Hospital (TGH) infection preventionists started an intervention that eliminated these infections completely from their 18-bed Cardiothoracic Intensive Care Unit (CTICU).

Meeting: APIC 2024 Annual Conference

People with well-controlled, long-duration type 1 diabetes may still face high risk of heart disease

The Endocrine Society
Meeting Announcement

People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

GLP-1 medications for type 2 diabetes and obesity may lower risk of acute pancreatitis

The Endocrine Society
Meeting Announcement

Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

35
36
37
38
39